Scarica l'app Stockscreener
4.59
2.46%
0.11
Pre-mercato:
4.65
0.06
+1.31%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.48
Aprire:
$4.46
Volume 24 ore:
1.31M
Relative Volume:
0.86
Capitalizzazione di mercato:
$248.74M
Reddito:
-
Utile/perdita netta:
$-54.19M
Rapporto P/E:
-1.7791
EPS:
-2.58
Flusso di cassa netto:
$-37.34M
1 W Prestazione:
+1.77%
1M Prestazione:
-16.24%
6M Prestazione:
-28.50%
1 anno Prestazione:
-23.24%
Intervallo 1D:
$4.42
$4.63
Intervallo di 1 settimana:
$4.16
$4.63
Portata 52W:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Nome
Abeona Therapeutics Inc
Settore
Industria
Telefono
646-813-4701
Indirizzo
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Confronta ABEO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
4.59 | 242.78M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.00 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.45 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.23 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
906.74 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.93 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-03-05 | Iniziato | Oppenheimer | Outperform |
| 2024-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-30 | Iniziato | Stifel | Buy |
| 2020-11-11 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Iniziato | B. Riley FBR | Buy |
| 2020-02-10 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Ripresa | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Downgrade | Maxim Group | Buy → Hold |
| 2019-08-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Downgrade | Mizuho | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2018-10-12 | Iniziato | Mizuho | Buy |
| 2018-06-05 | Iniziato | Seaport Global Securities | Buy |
| 2017-11-08 | Iniziato | SunTrust | Buy |
| 2017-10-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Iniziato | Citigroup | Buy |
| 2017-10-05 | Reiterato | Maxim Group | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-07-18 | Reiterato | Maxim Group | Buy |
| 2017-06-22 | Ripresa | Jefferies | Buy |
| 2017-01-06 | Iniziato | Jefferies | Buy |
| 2016-09-29 | Reiterato | Maxim Group | Buy |
Mostra tutto
Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie
Liquidity Mapping Around (ABEO) Price Events - news.stocktradersdaily.com
What technical patterns form on Abeona Therapeutics Inc. (PCJ) stock chartsJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
How Abeona Therapeutics Inc. (PCJ) stock behaves in tightening cyclesGold Moves & Verified Momentum Stock Alerts - newser.com
What downside risks could hit Abeona Therapeutics Inc. (PCJ) stockExit Point & Reliable Price Breakout Alerts - newser.com
Abeona Therapeutics Earnings Call: Positive Outlook Amid Challenges - MSN
Is Abeona Therapeutics Inc. (PCJ) stock positioned for digital growth eraIPO Watch & Low Risk Investment Opportunities - newser.com
Is Abeona Therapeutics Inc. (PCJ) stock trading at attractive multiples2025 Price Momentum & Weekly High Potential Alerts - newser.com
Visualizing Abeona Therapeutics Inc. stock with heatmapsVolume Spike & Community Trade Idea Sharing - newser.com
Will Abeona Therapeutics Inc. stock benefit from green energy trendsTrade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
Sentiment analysis tools applied to Abeona Therapeutics Inc.2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Is Abeona Therapeutics Inc a good long term investmentDividend Reinvestment Plans & Market-Leading Growth Rates - earlytimes.in
Is Abeona Therapeutics Inc. (PCJ) stock supported by free cash flowJuly 2025 Summary & Real-Time Volume Analysis Alerts - newser.com
Sector ETF performance correlation with Abeona Therapeutics Inc.2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
How Abeona Therapeutics Inc. stock reacts to inflationary pressuresMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Can Abeona Therapeutics Inc. (PCJ) stock survive global slowdownQuarterly Market Review & Weekly Return Optimization Plans - newser.com
Abeona Therapeutics: Q3 2025 Financial Insights - MSN
Director’s Bold Move: Abeona Therapeutics Stock Sale Shakes Market! - TipRanks
Insider Sell Alert: Mark Alvino Sells 15,000 Shares of Abeona Th - GuruFocus
Dir Alvino Sells 15,000 ($71.2K) Of Abeona Therapeutics Inc [ABEO] - TradingView
ABEONA THERAPEUTICS Director Mark Alvino Sells 15,000 Shares - TradingView
Abeona Therapeutics at Stifel 2025 Healthcare Conference: Strategic Progress and Challenges - Investing.com Canada
Abeona anticipates 2026 profitability as ZEVASKYN demand doubles and QTC network expands - MSN
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2025 Earnings Call Transcript - Insider Monkey
Abeona Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates - MarketScreener
Abeona Therapeutics (ABEO) Is Up 17.9% After Reporting Narrowed Losses and ZEVASKYN J-code Approval - Yahoo Finance
Abeona Therapeutics: Q3 Earnings Snapshot - New Haven Register
Abeona Therapeutics Inc Azioni (ABEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.13%
4.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):